Evolution of Rheumatoid-Arthritis-Associated Interstitial Lung Disease in Patients Treated with JAK Inhibitors: A Retrospective Exploratory Study.
Vincenzo VeneritoAndreina ManfrediAntonio CarlettoStefano GentileschiFabiola AtzeniSerena GuiducciMarlea LavistaLaura La CorteElisa PedrolloArnaldo ScardapaneCaterina TomassiniBruno FredianiCarlo SalvaraniFlorenzo IannoneMarco SebastianiPublished in: Journal of clinical medicine (2023)
This study suggests that JAKi therapy might be a safe therapeutic option for patients with RA-ILD in a short-term follow-up.